Cemera.cl

REVISTA DE LASOCIEDAD CHILENA DEOBSTETRICIA Y GINECOLOGIAINFANTIL Y DE LA ADOLESCENCIA Polycystic Ovary Syndrome In Teenagers: Clinical, Laboratory and Ultrasound Evaluation and Treatment. / Sotomayor Karina y cols. Polycystic Ovary Syndrome In Teenagers: Clinical, Laboratory and Ultrasound Evaluation and Treatment. p.024 Sotomayor Karina, Barrera C., Flández J. Centro de Docencia de Atención Clínica Integral Ambulatoria, Facultad de Medicina, Universidad Austral de Chile, Valdivia, Chile. se (body mass index (BMI)> or = 95th percentile, 1) To compare the clinical and laboratory fea- NCHS/OMS) and at-risk adolescents (BMI 85th to tures of obese versus eutrophic teenagers with Po- <95th percentile), and group 2: eutrophic teenagers (BMI 10th to 84th percentile). MBS was assessed 2) To assess the presence of metabolic syndro- (Ferranti criteria ATP III). Additionally to the obe- se teenagers were indicated by healthy diet, regular 3) To evaluate clinically the diet, exercise and exercise and Metformin (850 mg two times daily) Metformin treatment in obese teenagers with if insulin level was altered. They were evaluated by weight, BMI, hirsutism score (Ferriman Gallwey) and menstrual regularity at 3,6,12 and 18 months. Descriptive statistical analysis and some parame- Transversal study of 23 teenagers evaluated in ters analytic statistic were done. Using STATA 8.0, Pediatric Gynaecology Unit, with PCOS diagnosed with p value significative <0.05.
by the 2003 Rotterdam diagnostic criteria. They were evaluated clinically and sonographically and hormone plasma levels were measured: prolac- The mean age of 23 adolescents was 15 years tin, thyroid stimulating hormone (TSH), 17-OH- old (range: 12-19) and their gynaecological mean progesterone, dehydroepiandrosterone sulphate age was 3 years (range: 6 months-8 years). The (DHEA-S), androstenedione, total testosterone mean weight was 64.7 kg (range: 42.5-100.5), (Tt), sexual hormone binding globulin (SHBG) and mean BMI was 25.2 kg/m2 (range: 18.6-35.2).17 free androgens index (FAI) from Tt and SHBG was of them (74%) consulted by menstrual irregulari- calculated. Lipid profile: total cholesterol, high- ties, 5 (22%) by clinical hyperandrogenism (acne density lipoprotein (HDL), low-density lipoprotein or hirsutism) and just 1 consulted by obesity. Ante- (LDL), triglycerides (TG) and oral glucose tole- cedents of girl born small for gestational age were rance test with fasting and post charge glucose 2 present at 3 (13%), premature pubarche at 1 (4%), hours insulin were measured too. Index of insulin precocious menarche at 1 (4%) and family history resistance from glucose and insulin levels: the ho- of type 2 diabetes mellitus at 14 (61%). 12 (52%) meostasis model assessment (HOMA) was calcu- adolescents were obese (group 1) and 11 (48%) lated. Two groups were compared: group 1: obe- were eutrophic teenagers (group 2). Clinical featu- SOGIA Vol. 14 - Nº 3, Año 2007 - AV - Pág. 55
Polycystic Ovary Syndrome In Teenagers: Clinical, Laboratory and Ultrasound Evaluation and Treatment. / Sotomayor Karina y cols.
res as blood pressure, acanthosis nigricans, acne, 12 months and 10 (91%) restored normal men- Ferriman-Gallwey score and menstrual cycle strual cycles at 3 months post therapy. Just one were similar in both groups.14 (61%) ultrasound adolescent restored normal menses at 12 months were altered, 10 with polycystic ovaries and 4 post therapy, with the highest insulin levels.
with enlarged ovaries. There wasn`t difference between both groups. Prolactin, TSH, lipid profi- le, 17-OH-progesterone, DHEA-S, Tt, SHBG le- 1) Approximately 50% of our adolescents with vels and FAI didn´t show significative association PCOS were obese, coincident with literature. with nutritional status (p>0,05). Basal and post- 2) We observed a significative association bet- charge insulin were altered in 50% (group 1) vs ween insulin levels with nutritional status, sug- 9% (group 2) and 90% (group 1) vs 37% (group gesting that PCOS and obesity may have a sy- 2) respectively. Statistical significative associa- nergistic effect on the magnitude of the insulin tion was found between altered basal (p=0,032) and postcharge insulin (p=0,013), OR:16.6 (con- 3) MBS was present in 2 patients (9%), both fidence interval 1,36,204)95 with nutritional sta- with the highest insulin levels and BMI, sugges- tus. HOMA index was altered in 100% of obese ting hyperinsulinemia is a likely common patho- adolescents (group 1) vs 57% (group 2). MBS genetic factor for both PCOS and MBS.
was detected in 2 adolescents, both obese, with 4) The most of our adolescents restored nor- the highest BMI (35.2 and 33.1 kg/m2). 11 obe- mal menses at 3 months post therapy coincident se adolescents received diet, regular exercise and with literature. Just 1 needed 12 months to achie- Metformin therapy. 7 (64%) presented a descent ve ovulatory menses. The elevated insulin levels of weight over 5% at 6 months, the mean Ferri- in this patient suggest that insulin disorder may man-Gallwey score descended in three points at be the mean factor to anovulatory cycles.
SOGIA Vol. 14 - Nº 3, Año 2007 - AV - Pág. 56

Source: http://www.cemera.cl/sogia/pdf/2007/SOGIA_3_2007_2.pdf

legacy.vg

Affiliated with Baylor College of Medicine Gina McAfee hard at work. Gina and her family support Menninger because they have seen the benefits of superb mental healthcare. The organization has an 83-year husband, Rob, knew there was tradition of success in improving something about her daughter. mental health services, education L. was an intense child, and research for the country and perfe

Highlights of the 66th annual scientific meeting of the american college of gastroenterology

Highlights of the 66th Annual Scientific Meeting of the American College of Gastroenterology by Lawrence M. Prescott, PhD Las Vegas, Nevada was the venue for nearly 3,000 recent studies included new therapeutic approaches andgastroenterologists, research scientists, nurses, and othernovel agents for the treatment of gastroesophageal reflux healthcare professionals attending the 66th

Copyright © 2010-2018 Pharmacy Drugs Pdf